Yuhan to develop cell therapy with adult stem cell technologies.

Published: 2005-10-24 06:55:00

Updated: 2005-10-24 06:55:00

Two companies, Yuhan, one of big Koean pharmaceutical companies in Korea, and R&L Bio, one of biotech companies having the most advanced bio pharmaceutical technology in Korea announced to sign a joint research agreement as of Oct. 19 for the cell therapy by the use of adult stem cell technologies.

R&L Bio will provide an adult stem cell technology to Yuhan while Yuhan seek to commercialize...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.